Mina Gaga Selected Research

prostaglandin D2 receptor

1/2021

Effectiveness of fevipiprant in reducing exacerbations in patients with severe asthma (LUSTER-1 and LUSTER-2): two phase 3 randomised controlled trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mina Gaga Research Topics

Disease

29	Asthma (Bronchial Asthma) 09/2022 - 05/2005
11	Chronic Obstructive Pulmonary Disease (COPD) 11/2022 - 05/2005
7	Inflammation (Inflammations) 01/2022 - 05/2009
6	Extensively Drug-Resistant Tuberculosis 01/2019 - 01/2016
4	Lung Neoplasms (Lung Cancer) 09/2021 - 10/2017
3	Hypersensitivity (Allergy) 03/2022 - 12/2015
3	Pneumonia (Pneumonitis) 11/2020 - 10/2013
2	Neoplasms (Cancer) 09/2021 - 01/2019
2	Sarcoidosis (Schaumann Disease) 01/2020 - 07/2014
2	Airway Remodeling 12/2015 - 08/2012
1	Seasonal Allergic Rhinitis (Hay Fever) 03/2022
1	Melanoma (Melanoma, Malignant) 09/2021
1	Lewis Lung Carcinoma 09/2021
1	Neoplasm Metastasis (Metastasis) 09/2021
1	Disease Progression 09/2021
1	Noncommunicable Diseases 01/2021
1	Tobacco Use Disorder (Nicotine Dependence) 01/2021
1	COVID-19 11/2020
1	Cytokine Release Syndrome 11/2020
1	Lung Injury 11/2019
1	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2019
1	Pneumothorax 01/2019
1	Pulmonary Tuberculosis 01/2019
1	Hemorrhage 01/2019
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2019
1	Adenocarcinoma 12/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2015
1	Granuloma 07/2014
1	Hepatitis 10/2013
1	Transitional Cell Carcinoma 10/2013
1	Jaundice (Icterus) 10/2013
1	Sepsis (Septicemia) 10/2013

Drug/Important Bio-Agent (IBA)

12	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2022 - 02/2013
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2014
6	SteroidsIBA 01/2022 - 01/2007
4	GoldIBA 07/2021 - 01/2007
4	Biological ProductsIBA 01/2020 - 01/2019
3	SmokeIBA 01/2021 - 05/2005
3	Monoclonal AntibodiesIBA 01/2020 - 12/2015
3	Interleukin-5 (Interleukin 5)IBA 01/2020 - 01/2007
3	Pharmaceutical PreparationsIBA 11/2019 - 07/2005
3	Immunoglobulin E (IgE)IBA 12/2016 - 01/2007
3	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 05/2016 - 01/2016
2	mepolizumabIBA 09/2022 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2012
2	CytokinesIBA 09/2021 - 03/2016
2	activin AIBA 09/2021 - 03/2016
2	Omalizumab (Xolair)FDA Link 01/2021 - 12/2015
2	MacrolidesIBA 01/2020 - 01/2007
2	anti-IgE antibodiesIBA 01/2020 - 12/2015
2	Tiotropium Bromide (Spiriva)FDA Link 01/2020 - 01/2016
2	bedaquiline (R207910)IBA 01/2019 - 01/2017
2	indacaterolIBA 01/2018 - 01/2017
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2018 - 01/2017
2	ErbB Receptors (EGF Receptor)IBA 12/2017 - 10/2015
2	Imipenem FDA Link 05/2016 - 01/2016
2	Meropenem (Merrem)FDA LinkGeneric 04/2016 - 01/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2016 - 01/2016
2	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2007 - 07/2005
1	TabletsIBA 03/2022
1	Blood Proteins (Serum Proteins)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 09/2021
1	PeriostinIBA 01/2021
1	prostaglandin D2 receptorIBA 01/2021
1	fevipiprantIBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2020
1	Thymic Stromal LymphopoietinIBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	dupilumabIBA 01/2020
1	Interleukin-5 Receptors (Interleukin 5 Receptor)IBA 01/2020
1	tezepelumabIBA 01/2020
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2020
1	Calcifediol (Calcidiol)FDA Link 01/2020
1	InterleukinsIBA 01/2020
1	Interleukin-13IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	SolutionsIBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 12/2017
1	Muscarinic AntagonistsIBA 01/2017
1	PowdersIBA 01/2016
1	FluoroquinolonesIBA 01/2016
1	Bronchodilator Agents (Bronchodilators)IBA 01/2016
1	B-Cell Activating FactorIBA 01/2016
1	Antigen-Antibody Complex (Immune Complex)IBA 12/2015
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2015
1	AcidsIBA 07/2014
1	Granzymes (Granzyme)IBA 10/2013
1	PerforinIBA 10/2013
1	SA 76IBA 07/2013
1	ORALIT (ORS)IBA 07/2013
1	Cholinergic Antagonists (Anticholinergics)IBA 02/2013

Therapy/Procedure

16	Therapeutics 01/2021 - 05/2005
2	Immunotherapy 11/2019 - 10/2013
2	Nebulizers and Vaporizers (Inhaler) 01/2018 - 01/2016
1	Precision Medicine 01/2020
1	Duration of Therapy 04/2018
1	Continuity of Patient Care 09/2015
1	Intravesical Administration 10/2013